SIREN : 519123343
GSK is a French company founded 16 years ago, specialized in the sector Construction d'autres bâtiments. Based in LE TAMPON (97430), this company of category PME shows in 2021 a revenue of 1.0 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-02
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|
| Revenue | 1 029 175 € | 454 313 € | 436 149 € | 152 723 € |
| Net income | 17 971 € | 25 894 € | 104 141 € | -18 855 € |
| EBITDA | 23 319 € | 19 680 € | 101 276 € | -2 830 € |
| Net margin | 1.7% | 5.7% | 23.9% | -12.3% |
In 2021, GSK achieves revenue of 1.0 M€. Over the period 2018-2021, the company shows strong growth with a CAGR (compound annual growth rate) of +88.9%. Vs 2020, growth of +127% (454 k€ -> 1.0 M€). After deducting consumption (182 k€), gross margin stands at 848 k€, i.e. a rate of 82%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 23 k€, representing 2.3% of revenue. Warning negative scissor effect: despite revenue change (+127%), EBITDA varies by +18%, reducing margin by 2.1 pts. This reflects costs rising faster than revenue. The operating margin remains fragile, requiring cost vigilance. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 18 k€, i.e. 1.7% of revenue. This profit can be retained or distributed to shareholders.
1 029 175 €
847 591 €
23 319 €
18 643 €
17 971 €
2.3%
The debt ratio (= Financial debt / Equity x 100) stands at 79%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 31%. The balance between equity and debt is satisfactory. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 3.5 years of cash flow to repay all financial debt. This ratio remains within usual banking standards. Cash flow represents 2.2% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment.
78.511%
31.176%
2.193%
3.544
57.7%
In 2021, the debt ratio of GSK (78.51) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
In 2021, the financial autonomy of GSK (31.2%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
In 2021, the repayment capacity of GSK (3.54) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
The liquidity ratio (= Current assets / Current liabilities) stands at 172.54. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 2.9x. Financial charges are adequately covered by operations.
172.536
2.882
In 2021, the liquidity ratio of GSK (172.54) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
In 2021, the interest coverage of GSK (2.9x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 5 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 59 days. Excellent situation: suppliers finance 54 days of the operating cycle (retail model). Inventory turnover is 22 days (= Average inventory / Cost of goods x 360). Fast turnover, sign of good inventory management. Overall, WCR represents 21 days of revenue, i.e. 60 k€ to permanently finance. Over 2018-2021, WCR increased by +362%, requiring additional financing.
60 289 €
5 j
59 j
22 j
21 j
Indicative estimate only : the number of comparable transactions in this sector is limited (23 transactions). This range of 54 816€ to 410 051€ is provided for information purposes only and requires in-depth analysis to be confirmed.
This estimate is based on the analysis of 23 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare GSK with other companies in the same sector:
Voir toutes les statistiques du secteur Construction d'autres bâtiments
The revenue of GSK in 2021 is 1.0 M€.
Yes, GSK generated a net profit of 18 k€ in 2021.
The headquarters of GSK is located in LE TAMPON (97430), in the department La Reunion.
The tax return of GSK is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
GSK operates in the sector Construction d'autres bâtiments (NAF code 41.20B). See the 'Sector positioning' section above to compare the company with its competitors.